ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Investor Feedback and Sentiment (Post #85): The Daily Catch: 2Q26 Pre-Quiet Period Catch-Ups: CMG and FWRG

Published: 2026-06-23Institution: CitiPages: 11Original language: EnglishEvidence page: 1

Research evidence excerpt

Investor Feedback and Sentiment (Post #85): The Daily Catch: 2Q26 Pre-Quiet Period Catch-Ups: CMG and FWRG

Off the Cuff |

23 Jun 2026 05:00:11 ET │ 11 pages

Investor Feedback and Sentiment (Post #85)

The Daily Catch: 2Q26 Pre-Quiet Period Catch-Ups: CMG and FWRG

We caught up with teams at CMG and FWRG ahead of 2Q26 quiet periods. Key points:

CMG:

– The company’s made-from-scratch cooking is a competitive advantage that the

new CMO has been tasked to better highlight through marketing. This advantage also

comes as an impediment to the cadence of innovation as full in-house product prep Jon Tower, CFAAC

requires greater labor/time commitment relative to many quick-service/fast-casual +1-212-816-6238

competitors. CMG continues to build out its pantry of core (e.g., protein) and non-core jon.tower@citi.com

menu options (e.g., potentially seasoned chips soon).

– For delivery, 3PD has been one of CMG’s best-comping channels over the past 12-

18 months and the company has tested lower premiums vs. in-store, but to-date

there have been no strong conclusions regarding how to proceed in part because 3rd-

party platforms use different algos to promote brands.

– CMG continues to tweak the catering platform, but believes learnings-to-date will

provide for broader expansion of the platform in ’27.

– On operations, the company is exploring other options around in-store order

payment that may integrate pay + loyalty and expedite thru-put without adding

another pin pad to the front line.

– On modeling, guidance for other opex being higher Yr/Yr is in part due to increase

utility costs.

FWRG:

– Similar to what we observed in our survey work, FWRG believes the brand is well-

suited to navigate a broadening of consumer access to GLP-1 medications with its

current offering.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer